Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology

Journal of Cellular Physiology

Volumn 224, Issue 3, 2010, Pages 605-611

  Beattie, James ^a   McIntosh, Lisa ^b   Van Der Walle, Christopher F ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; FIBRONECTIN; INTEGRIN; INTEGRIN LINKED KINASE; INTEGRIN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; RECEPTOR FOR ACTIVATED C KINASE 1; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN; VITRONECTIN RECEPTOR;

CELL FUNCTION; EXTRACELLULAR MATRIX; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

CELL PHYSIOLOGICAL PHENOMENA; EXTRACELLULAR MATRIX; FIBRONECTINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTEGRINS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; VITRONECTIN;

EID: 77954584972     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22183     Document Type: Review

References (126)

1. Adamo ML, Neuenschwander S, LeRoith D, Roberts CT, Jr. 1993. Structure, expression, and regulation of the IGF-I gene. Adv Exp Med Biol 343:1-11. (Pubitemid 24059271)
2. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR. 2007. The integrin-growth factor receptor duet. J Cell Physiol 213:649-653.
3. Altroff H, van der Walle CF, Asselin J, Fairless R, Campbell ID, Mardon HJ. 2001. The eighth FIII domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth FIII domain. J Biol Chem 276:38885-38892. (Pubitemid 37371252)
4. Ando Y, Jensen PJ. 1993. Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J Invest Dermatol 100:633-639. (Pubitemid 23128358)
5. Aota S, Nomizu M, Yamada KM. 1994. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 269:24756-24761. (Pubitemid 24311733)
6. Aplin JD, Lacey H, Haigh T, Jones CJ, Chen CP, Westwood M. 2000. Growth factor-extracellular matrix synergy in the control of trophoblast invasion. Biochem Soc Trans 28:199-202. (Pubitemid 30103241)
7. Balbona K, Tran H, Godyna S, Ingham KC, Strickland DK, Argraves WS. 1992. Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J Biol Chem 267:20120-20125.
8. Balian G, Click EM, Bornstein P. 1980. Location of a collagen-binding domain in fibronectin. J Biol Chem 255:3234-3236.
9. Baserga R, Sell C, Porcu P, Rubini M. 1994. The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif 27:63-71. (Pubitemid 24053398)
10. Baudoin C, Goumans MJ, Mummery C, Sonnenberg A. 1998. Knockout and knockin of the beta1 exon D define distinct roles for integrin splice variants in heart function and embryonic development. Genes Dev 12:1202-1216. (Pubitemid 28194055)
11. Beattie J, Allan GJ, Lochrie JD, Flint DJ. 2006. Insulin-like growth factor-binding protein-5 (IGFBP-5): A critical member of the IGF axis. Biochem J 395:1-19.
12. Beattie J, Kreiner M, Allan GJ, Flint DJ, Domingues D, van der Walle CF. 2009. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin. Biochem Biophys Res Commun 381:572-576.
13. Besson A, Wilson TL, Yong VW. 2002. The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. J Biol Chem 277:22073-22084.
14. Boettiger D, Lynch L, Blystone S, Huber F. 2001. Distinct ligand-binding modes for integrin alpha(v)beta(3)-mediated adhesion to fibronectin versus vitronectin. J Biol Chem 276:31684-31690.
15. Brooks PC, Klemke RL, Schon S, Lewis JM, Schwartz MA, Cheresh DA. 1997. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J Clin Invest 99:1390-1398. (Pubitemid 27142777)
16. Bunkenborg J, Pilch BJ, Podtelejnikov AV, Wisniewski JR. 2004. Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 4:454-465. (Pubitemid 38235265)
17. Calderwood DA, Fujioka Y, de Pereda JM, Garcia-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC, Ginsberg MH. 2003. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains:Astructural prototype for diversity in integrin signaling. Proc Natl Acad Sci USA 100:2272-2277.
18. Chang BY, Conroy KB, Machleder EM, Cartwright CA. 1998. RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells. Mol Cell Biol 18:3245-3256.
19. Charo IF, Nannizzi L, Smith JW, Cheresh DA. 1990. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 111:2795-2800.
20. Clemmons DR. 2001. Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr Rev 22:800-817.
21. Clemmons DR, Maile LA. 2003. Minireview: Integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology 144:1664-1670.
22. Clemmons DR, Maile LA. 2005. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: Cellular responses to changes in multiple signaling inputs. Mol Endocrinol 19:1-11.
23. Clemmons DR, Jones JI, Busby WH, Wright G. 1993. Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci 692:10-21. (Pubitemid 23299512)
24. Clemmons DR, Horvitz G, Engleman W, Nichols T, Moralez A, Nickols GA. 1999. Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication. Endocrinology 140:4616-4621. (Pubitemid 30666128)
25. De Meyts P, Whittaker J. 2002. Structural biology of insulin and IGF1 receptors: Implications for drug design. Nat Rev Drug Discov 1:769-783. (Pubitemid 37361561)
26. Delannet M, Martin F, Bossy B, Cheresh DA, Reichardt LF, Duband JL. 1994. Specific roles of the alpha V beta 1, alpha V beta 3 and alpha V beta 5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development 120:2687-2702. (Pubitemid 2131512)
27. Doerr ME, Jones JI. 1996. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem 271:2443-2447. (Pubitemid 26047847)
28. Driver GA, Veale RB. 2006. Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors. Cancer Cell Int 6:12.
29. Edderkaoui M, Hong P, Lee JK, Pandol SJ, Gukovskaya AS. 2007. Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin. J Biol Chem 282:26646-26655. (Pubitemid 47501963)
30. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854. (Pubitemid 35454590)
31. Galiano RD, Zhao LL, Clemmons DR, Roth SI, Lin X, Mustoe TA. 1996. Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model. J Clin Invest 98:2462-2468. (Pubitemid 26415066)
32. Gleeson LM, Chakraborty C, McKinnon T, Lala PK. 2001. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab 86:2484-2493. (Pubitemid 32545696)
33. Gockerman A, Prevette T, Jones JI, Clemmons DR. 1995. Insulin-like growth factor (IGF)- binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136:4168-4173.
34. Goel HL, Fornaro M, Moro L, Teider N, Rhim JS, King M, Languino LR. 2004. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins. J Cell Biol 166:407-418.
35. Grant RP, Spitzfaden C, Altroff H, Campbell ID, Mardon HJ. 1997. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem 272:6159-6166. (Pubitemid 27118083)
36. Guillemot F, Billault A, Auffray C. 1989. Physical linkage of a guanine nucleotide-binding protein-related gene to the chicken major histocompatibility complex. Proc Natl Acad Sci USA 86:4594-4598.
37. Hayashi M, Schlesinger DH, Kennedy DW, Yamada KM. 1980. Isolation and characterization of a heparin-binding domain of cellular fibronectin. J Biol Chem 255:10017-10020. (Pubitemid 11214576)
38. Hayman EG, Pierschbacher MD, Ohgren Y, Ruoslahti E. 1983. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 80:4003-4007.
39. Hazelgrove KB, Flynn RS, Qiao LY, Grider JR, Kuemmerle JF. 2009. Endogenous IGF-I and alpha v beta3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 296:G1230-G1237.
40. Hermanto U, Zong CS, Li W, Wang LH. 2002. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol 22:2345-2365. (Pubitemid 34224638)
41. Humphries JD, Byron A, Humphries MJ. 2006. Integrin ligands at a glance. J Cell Sci 119:3901-3903.
42. Imai Y, Clemmons DR. 1999. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology 140:4228-4235. (Pubitemid 30647121)
43. Jenne D, Stanley KK. 1985. Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J 4:3153-3157.
44. Jenne D, Stanley KK. 1987. Nucleotide sequence and organization of the human S-protein gene: Repeating peptide motifs in the "pexin" family and a model for their evolution. Biochemistry 26:6735-6742.
45. Jones GE, Arumugham RG, Tanzer ML. 1986. Fibronectin glycosylation modulates fibroblast adhesion and spreading. J Cell Biol 103:1663-1670.
46. Jones JI, Gockerman A, Busby WH, Jr., Wright G, Clemmons DR. 1993. Insulin-like growth factor binding protein 1 stimulates cellmigration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-10557.
47. Jung KY, Chen K, Kretzler M, Wu C. 2007. TGF-beta1 regulates the PINCH-1-integrin-linked kinase-alpha-parvin complex in glomerular cells. J Am Soc Nephrol 18:66-73. (Pubitemid 46053423)
48. Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Nagamatsu S, Sakai K, Nakamura Y, Lotfi A, Kawakami H, Iwashita M. 2003. Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology 144:1620-1630.
49. Kiely PA, Sant A, O'Connor R. 2002. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem 277:22581-22589. (Pubitemid 34967235)
50. Kiely PA, O'Gorman D, Luong K, Ron D, O'Connor R. 2006. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration. Mol Cell Biol 26:4041-4051. (Pubitemid 43788008)
51. Kiely PA, Baillie GS, Lynch MJ, Houslay MD, O'Connor R. 2008. Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration. J Biol Chem 283:22952-22961.
52. Kricker JA, Towne CL, Firth SM, Herington AC, Upton Z. 2003. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144:2807-2815. (Pubitemid 36819880)
53. Kubomura S, Obara M, Karasaki Y, Taniguchi H, Gotoh S, Tsuda T, Higashi K, Ohsato K, Hirano H. 1987. Genetic analysis of the cell binding domain region of the chicken fibronectin gene. Biochim Biophys Acta 910:171-181.
54. Kuemmerle JF. 2006. Occupation of alphavbeta3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 290:G1194-G1202.
55. Lebrun P, Mothe-Satney I, Delahaye L, Van Obberghen E, Baron V. 1998. Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src). J Biol Chem 273:32244-32253.
56. Li Y, Yang J, Dai C, Wu C, Liu Y. 2003. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112:503-516. (Pubitemid 38056335)
57. Liliental J, Chang DD. 1998. Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem 273:2379-2383. (Pubitemid 28069294)
58. Ling Y, Maile LA, Clemmons DR. 2003. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for membrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor. Mol Endocrinol 17:1824-1833. (Pubitemid 37072298)
59. Ling Y, Maile LA, Badley-Clarke J, Clemmons DR. 2005. DOK1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells. J Biol Chem 280:3151-3158. (Pubitemid 40223776)
60. Liu T, Qian WJ, Gritsenko MA, Camp DGII, Monroe ME, Moore RJ, Smith RD. 2005. Human plasmaN-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 4:2070-2080. (Pubitemid 41814273)
61. Maile LA, Clemmons DR. 2002a. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Srchomology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocrinology 143:4259-4264.
62. Maile LA, Clemmons DR. 2002b. Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2. J Biol Chem 277:8955-8960.
63. Maile LA, Badley-Clarke J, Clemmons DR. 2001. Structural analysis of the role of the beta 3 subunit of the alpha V beta 3 integrin in IGF-I signaling. J Cell Sci 114:1417-1425. (Pubitemid 32409477)
64. Maile LA, Imai Y, Clarke JB, Clemmons DR. 2002. Insulin-like growth factor I increases alpha Vbeta 3 affinity by increasing the amount of integrin-associated protein that is associated with non-raft domains of the cellular membrane. J Biol Chem 277:1800-1805. (Pubitemid 34968752)
65. Maile LA, Badley-Clarke J, Clemmons DR. 2003. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Mol Biol Cell 14:3519-3528. (Pubitemid 37151605)
66. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons DR. 2006a. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Mol Endocrinol 20:405-413.
67. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Ling Y, Clemmons DR. 2006b. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol Endocrinol 20:881-892.
68. Maile LA, Capps BE, Miller EC, Aday AW, Clemmons DR. 2008. Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates IGF-I signaling in vivo. Diabetes 57:2637-2643.
69. Mandel U, Hamilton Therkildsen M, Reibel J, Sweeney B, Matsuura H, Hakomori S, Dabelsteen E, Clausen H. 1992. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies. APMIS 100:817-826.
70. Manes S, Mira E, Gomez-Mouton C, Zhao ZJ, Lacalle RA, Martinez AC. 1999. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol 19:3125-3135.
71. Mao Y, Schwarzbauer JE. 2005. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24:389-399.
72. Marelli MM, Moretti RM, Procacci P, Motta M, Limonta P. 2006. Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling. Int J Oncol 28:723-730.
73. Martin JA, Miller BA, Scherb MB, Lembke LA, Buckwalter JA. 2002. Co-localization of insulinlike growth factor binding protein 3 and fibronectin in human articular cartilage. Osteoarthritis Cartilage 10:556-563.
74. Matsumoto H, Sakai K, Iwashita M. 2008. Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via alpha5beta1 integrin. Mol Hum Reprod 14:485-489.
75. Mauro L, Sisci D, Bartucci M, Salerno M, Kim J, Tam T, Guvakova MA, Ando S, Surmacz E. 1999. SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility. Exp Cell Res 252:439-448.
76. McCahill A, Warwicker J, Bolger GB, Houslay MD, Yarwood SJ. 2002. The RACK1 scaffold protein: A dynamic cog in cell response mechanisms. Mol Pharmacol 62:1261-1273.
77. McDonald PC, Fielding AB, Dedhar S. 2008. Integrin-linked kinase - Essential roles in physiology and cancer biology. J Cell Sci 121:3121-3132.
78. Nakasaki M, Yoshioka K, Miyamoto Y, Sasaki T, Yoshikawa H, Itoh K. 2008. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 43:869-879.
79. Nam T, Moralez A, Clemmons D. 2002. Vitronectin binding to IGF binding protein-5 (IGFBP- 5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 143:30-36.
80. Nichols TC, du Laney T, Zheng B, Bellinger DA, Nickols GA, Engleman W, Clemmons DR. 1999. Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling. Circ Res 85:1040-1045.
81. Obara M, Kang MS, Rocher-Dufour S, Kornblihtt A, Thiery JP, Yamada KM. 1987. Expression of the cell-binding domain of human fibronectin in E. coli. Identification of sequences promoting full to minimal adhesive function. FEBS Lett 213:261-264.
82. Obara M, Kang MS, Yamada KM. 1988. Site-directed mutagenesis of the cell-binding domain of human fibronectin: Separable, synergistic sites mediate adhesive function. Cell 53:649-657.
83. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. 2006. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635-648. (Pubitemid 44647421)
84. Pereira JJ, Meyer T, Docherty SE, Reid HH, Marshall J, Thompson EW, Rossjohn J, Price JT. 2004. Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res 64:977-984.
85. Perks CM, Newcomb PV, Norman MR, Holly JM. 1999. Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol 22:141-150. (Pubitemid 29193102)
86. Pierschbacher MD, Ruoslahti E. 1984. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33. (Pubitemid 14134132)
87. Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA. 2005. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol 166:399-407. (Pubitemid 40189037)
88. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. 2000. Ligand binding to integrins. J Biol Chem 275:21785-21788.
89. Ren Y, Meng S, Mei L, Zhao ZJ, Jove R, Wu J. 2004. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem 279:8497-8505. (Pubitemid 38294743)
90. Richter H, Seidl M, Hormann H. 1981. Location of heparin-binding sites of fibronectin. Detection of a hitherto unrecognized transamidase sensitive site. Hoppe Seylers Z Physiol Chem 362:399-408.
91. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. 1994. Cloning of an intracellular receptor for protein kinase C: A homolog of the beta subunit of G proteins. Proc Natl Acad Sci USA 91:839-843.
92. Rosano L, Spinella F, Di Castro V, Dedhar S, Nicotra MR, Natali PG, Bagnato A. 2006. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol Cancer Ther 5:833-842. (Pubitemid 43724582)
93. Rostagno AA, Schwarzbauer JE, Gold LI. 1999. Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin. Biochem J 338:375-386. (Pubitemid 129512261)
94. Ruoslahti E, Pierschbacher MD. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491-497. (Pubitemid 17147032)
95. Saegusa J, Yamaji S, Ieguchi K, Wu CY, Lam KS, Liu FT, Takada YK, Takada Y. 2009. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin {alpha}v{beta}3 is involved in IGF- 1 signaling. J Biol Chem 284:24106-24114.
96. Schutt BS, Langkamp M, Rauschnabel U, Ranke MB, Elmlinger MW. 2004. Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 32:859-868. (Pubitemid 38877689)
97. Schwartz MA, Ginsberg MH. 2002. Networks and crosstalk: Integrin signalling spreads. Nat Cell Biol 4:E65-E68.
98. Seger D, Gechtman Z, Shaltiel S. 1998. Phosphorylation of vitronectin by casein kinase II. Identification of the sites and their promotion of cell adhesion and spreading. J Biol Chem 273:24805-24813. (Pubitemid 28454985)
99. Sekiguchi K, Hakomori S. 1980. Identification of two fibrin-binding domains in plasma fibronectin and unequal distribution of these domains in two different subunits: A preliminary note. Biochem Biophys Res Commun 97:709-715. (Pubitemid 11152202)
100. Sekimoto H, Eipper-Mains J, Pond-Tor S, Boney CM. 2005. (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells. Mol Endocrinol 19:1859-1867.
101. Shakibaei M, John T, De Souza P, Rahmanzadeh R, Merker HJ. 1999. Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: Collaboration with the insulinlike growth factor-I receptor. Biochem J 342:615-623.
102. Siwanowicz I, Popowicz GM, Wisniewska M, Huber R, Kuenkele KP, Lang K, Engh RA, Holak TA. 2005. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure 13:155-167. (Pubitemid 40092483)
103. Smith JW, Vestal DJ, Irwin SV, Burke TA, Cheresh DA. 1990. Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin. J Biol Chem 265:11008-11013. (Pubitemid 20200096)
104. Sondek J, Siderovski DP. 2001. Gamma-like (GGL) domains: New frontiers in G-protein signaling and beta-propeller scaffolding. Biochem Pharmacol 61:1329-1337. (Pubitemid 32452348)
105. Sureshbabu A, Okajima H, Yamanaka D, Shastri S, Tonner E, Rae C, Szymanowska M, Shand JH, Takahashi S, Beattie J, Allan GJ, Flint DJ. 2009. IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response. Biochem Soc Trans 37:882-885.
106. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E. 1985. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 4:2519-2524.
107. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. 2003. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling. Cancer Res 63:5850-5858.
108. Tapley P, Horwitz A, Buck C, Duggan K, Rohrschneider L. 1989. Integrins isolated from Rous sarcoma virus-transformed chicken embryo fibroblasts. Oncogene 4:325-333. (Pubitemid 19089730)
109. Tressel T, McCarthy JB, Calaycay J, Lee TD, Legesse K, Shively JE, Pande H. 1991. Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region. Biochem J 274:731-738.
110. Upton Z, Cuttle L, Noble A, Kempf M, Topping G, Malda J, Xie Y, Mill J, Harkin DG, Kravchuk O, Leavesley DI, Kimble RM. 2008. Vitronectin:Growth factor complexes hold potential as a wound therapy approach. J Invest Dermatol 128:1535-1544.
111. Valentinis B, Baserga R. 2001. IGF-I receptor signalling in transformation and differentiation. Mol Pathol 54:133-137.
112. Van Lonkhuyzen DR, Hollier BG, Shooter GK, Leavesley DI, Upton Z. 2007. Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors. Growth Factors 25:295-308. (Pubitemid 351194028)
113. von der Mark H, Williams I, Wendler O, Sorokin L, von der Mark K, Poschl E. 2002. Alternative splice variants of alpha 7 beta 1 integrin selectively recognize different laminin isoforms. J Biol Chem 277:6012-6016. (Pubitemid 34968384)
114. Waite KA, Mugnai G, Culp LA. 1987. A second cell-binding domain on fibronectin (RGDSindependent) for neurite extension of human neuroblastoma cells. Exp Cell Res 169:311-327. (Pubitemid 17056598)
115. Walker JL, Zhang L, Zhou J, Woolkalis MJ, Menko AS. 2002. Role for alpha 6 integrin during lens development: Evidence for signaling through IGF-1R and ERK. Dev Dyn 223:273-284.
116. Wang GK, Hu L, Fuller GN, Zhang W. 2006. An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem 281:14085-14091. (Pubitemid 43848335)
117. White ES, Baralle FE, Muro AF. 2008. Newinsights into form and function of fibronectin splice variants. J Pathol 216:1-14.
118. Xi G, Maile LA, Yoo SE, Clemmons DR. 2008. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation. J Cell Physiol 214:306-315. (Pubitemid 350308986)
119. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, Arnaout MA. 2001. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294:339-345.
120. Xu Q, Yan B, Li S, Duan C. 2004. Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes its ligand-dependent action on cell migration. J Biol Chem 279:4269-4277. (Pubitemid 38199014)
121. Yasuoka H, Jukic DM, Zhou Z, Choi AM, Feghali-Bostwick CA. 2006a. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Arthritis Rheum 54:3001-3010. (Pubitemid 44497782)
122. Yasuoka H, Zhou Z, Pilewski JM, Oury TD, Choi AM, Feghali-Bostwick CA. 2006b. Insulinlike growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am J Pathol 169:1633-1642. (Pubitemid 351181995)
123. Yasuoka H, Yamaguchi Y, Feghali-Bostwick CA. 2009. The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am J Respir Cell Mol Biol 41:179-188.
124. Zhang X, Yee D. 2002. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Res 62:4369-4375. (Pubitemid 34827295)
125. Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z, Wang LH. 2006. RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage- independent growth. Mol Cell Biol 26:413-424. (Pubitemid 43089756)
126. Zheng B, Clemmons DR. 1998. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:11217-11222.